Search Results - "Cossette, Travis"

Refine Results
  1. 1

    Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation by Onos, Kristen D, Uyar, Asli, Keezer, Kelly J, Jackson, Harriet M, Preuss, Christoph, Acklin, Casey J, O'Rourke, Rita, Buchanan, Rebecca, Cossette, Travis L, Sukoff Rizzo, Stacey J, Soto, Ileana, Carter, Gregory W, Howell, Gareth R

    Published in PLoS genetics (31-05-2019)
    “…Classical laboratory strains show limited genetic diversity and do not harness natural genetic variation. Mouse models relevant to Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  2. 2

    Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy by Keeler, Allison M, Conlon, Thomas, Walter, Glenn, Zeng, Huadong, Shaffer, Scott A, Dungtao, Fu, Erger, Kirsten, Cossette, Travis, Tang, Qiushi, Mueller, Christian, Flotte, Terence R

    Published in Molecular therapy (01-06-2012)
    “…Very long-chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid oxidation. VLCAD-deficient mice and patients clinical…”
    Get full text
    Journal Article
  3. 3

    In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA by Cruz, Pedro E, Mueller, Christian, Cossette, Travis L, Golant, Alexandra, Tang, Qiushi, Beattie, Stuart G, Brantly, Mark, Campbell-Thompson, Martha, Blomenkamp, Keith S, Teckman, Jeffrey H, Flotte, Terence R

    Published in Laboratory investigation (01-09-2007)
    “…α-1 Antitrypsin (AAT) deficiency is one of the most common genetic diseases in North America, with a carrier frequency of approximately 4% in the US…”
    Get full text
    Journal Article
  4. 4

    Model‐EyeD: Harnessing the potential of the eye as a biomarker for Alzheimer’s disease and related dementias by Howell, Gareth R, Marola, Olivia J, Maclean, Michael, Cossette, Travis L, Hewes, Amanda, Morgan, James, Singer, Cliff, Risacher, Shannon L., Onos, Kristen D, Reagan, Alaina M

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Disease‐modifying treatments for Alzheimer’s disease and related dementias (ADRD) will be most effective early in the disease process. Clinical use…”
    Get full text
    Journal Article
  5. 5

    Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa by Deng, Wen-Tao, Dyka, Frank M, Dinculescu, Astra, Li, Jie, Zhu, Ping, Chiodo, Vince A, Boye, Sanford L, Conlon, Thomas J, Erger, Kirsten, Cossette, Travis, Hauswirth, William W

    Published in Human gene therapy (01-09-2015)
    “…Our collaborative successful gene replacement therapy using AAV vectors expressing a variant of human RPGR-ORF15 in two canine models provided therapeutic…”
    Get more information
    Journal Article
  6. 6

    Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouse by Boye, Sanford L, Conlon, Thomas, Erger, Kirsten, Ryals, Renee, Neeley, Andy, Cossette, Travis, Pang, Jijing, Dyka, Frank M, Hauswirth, William W, Boye, Shannon E

    “…The authors previously showed that subretinal delivery of AAV5 vectors containing murine guanylate cyclase-1 (GC1) cDNA driven by either photoreceptor-specific…”
    Get full text
    Journal Article
  7. 7

    Dynamic bioinspired coculture model for probing ER + breast cancer dormancy in the bone marrow niche by Pradhan, Lina, Moore, DeVonte, Ovadia, Elisa M, Swedzinski, Samantha L, Cossette, Travis, Sikes, Robert A, van Golen, Kenneth, Kloxin, April M

    Published in Science advances (10-03-2023)
    “…Late recurrences of breast cancer are hypothesized to arise from disseminated tumor cells (DTCs) that reactivate after dormancy and occur most frequently with…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Recombinant AAV Serotype and Capsid Mutant Comparison for Pulmonary Gene Transfer of α-1-Antitrypsin Using Invasive and Noninvasive Delivery by Liqun Wang, Rejean, McLaughlin, Thomas, Cossette, Travis, Tang, Qiushi, Foust, Kevin, Campbell-Thompson, Martha, Martino, Ashley, Cruz, Pedro, Loiler, Scott, Mueller, Christian, Flotte, Terence R

    Published in Molecular therapy (01-01-2009)
    “…Recombinant adeno-associated viral (rAAV) vectors have been widely used in pulmonary gene therapy research. In this study, we evaluated the transduction and…”
    Get full text
    Journal Article
  12. 12

    Biodistribution and toxicology studies of AAV2/rh8-CBA- beta -hexosaminidase after intracranial delivery in C57/BI6 mice by Erger, Kirsten, Mandel, Ronald, Castleman, William, Campbell-Thompson, Martha, Abernathy, Corinne, Getz, Matthew, Cossette, Travis, Schneider, Lynda, Brown, Ryan, Sena-Esteves, Miguel, Conlon, Thomas

    Published in Molecular therapy (01-09-2013)
    “…Tay-Sachs disease (TSD) is an autosomal recessive neurodegenerative disease resulting from a lack of functional lysosomal enzyme [Beta]-N-acetylhexosaminidase…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector by Conlon, Thomas J, Walter, Glenn, Owen, Renius, Cossette, Travis, Erger, Kirsten, Gutierrez, Greg, Goetzman, Eric, Matern, Dietrich, Vockley, Jerry, Flotte, Terence R

    Published in Human gene therapy (01-01-2006)
    “…Mitochondrial beta-oxidation of fatty acids is required to meet physiologic energy requirements during illness and periods of fasting or physiologic stress,…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector by Conlon, Thomas J, Cossette, Travis, Erger, Kirsten, Choi, Young-Kook, Clarke, Tracy, Scott-Jorgensen, Marda, Song, Sihong, Campbell-Thompson, Martha, Crawford, James, Flotte, Terence R

    Published in Molecular therapy (01-11-2005)
    “…alpha1-Antitrypsin (AAT) deficiency is a single-gene disorder in which a mutation in the AAT (approved symbol SERPINA1) gene (PI*Z) leads to misfolding of the…”
    Get full text
    Journal Article